BioCorRx Inc. (BICX) Gross margin 2016–2024
BioCorRx Inc. (BICX) gross margin by fiscal year — reported gross profit divided by reported revenue.
78.3%FY2024 · since FY2016: 75.0% → 78.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | 78.3% | +18.6 pp |
| FY2023 | 59.6% | -33.2 pp |
| FY2022 | 92.9% | +5.0 pp |
| FY2021 | 87.8% | +66.1 pp |
| FY2020 | 21.8% | -44.3 pp |
| FY2019 | 66.0% | +11.4 pp |
| FY2018 | 54.6% | +3.8 pp |
| FY2017 | 50.8% | -24.2 pp |
| FY2016 | 75.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice